|
|
|
|
| LEADER |
02362nmm a2200361 u 4500 |
| 001 |
EB000363606 |
| 003 |
EBX01000000000000000216658 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9781461403791
|
| 100 |
1 |
|
|a Matijević, Egon
|e [editor]
|
| 245 |
0 |
0 |
|a Fine Particles in Medicine and Pharmacy
|h Elektronische Ressource
|c edited by Egon Matijević
|
| 250 |
|
|
|a 1st ed. 2012
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 2012, 2012
|
| 300 |
|
|
|a XIII, 348 p
|b online resource
|
| 505 |
0 |
|
|a Models of Size and Shape Control in Synthesis of Uniform Colloids and Nanocrystals -- Preparation of Uniform Drug Particles -- Biomedical Applications of Metal Oxides -- Biomedical Applications of Gold Nanoparticles -- Biomedical Applications of Magnetic Particles -- Degradable Polymer Particles for Biomedical Applications -- Functionalization of Inorganic Nanoparticles for Targeted Delivery -- Particle Deposition in the Human Respiratory Tract -- Detection of Oxidative Stress Biomarkers Using Functional Gold -- Stimuli-responsive Thin Films and Capsules: Approaching Smart Drug Delivery Systems -- Medicine in Reverse: Colloidal Technology for Combating Chemical Overdoses
|
| 653 |
|
|
|a Surface and Interface and Thin Film
|
| 653 |
|
|
|a Medicinal chemistry
|
| 653 |
|
|
|a Analytical chemistry
|
| 653 |
|
|
|a Pharmacy
|
| 653 |
|
|
|a Analytical Chemistry
|
| 653 |
|
|
|a Chemistry, Technical
|
| 653 |
|
|
|a Biotechnology
|
| 653 |
|
|
|a Medicinal Chemistry
|
| 653 |
|
|
|a Industrial Chemistry
|
| 653 |
|
|
|a Surfaces (Physics)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4614-0379-1
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4614-0379-1?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 660.6
|
| 520 |
|
|
|a Pharmaceutical manufacture is very exacting – for example, drugs must be uniform in size, shape, efficacy, bioavailability, and safety. The presence of different polymorphs in drug production is a serious problem, since different polymorphs differ in bioavailability, solubility, dissolution rate, chemical and physical stability, melting point, color, filterability, density, and flow properties. Fine Particles in Medicine and Pharmacy discusses particle size, shape, and composition and how they determine the choice of polymorph of a drug
|